BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16996498)

  • 1. Generation of a novel proform of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein that can be reactivated by matrix metalloproteinases.
    Shin JN; Park SY; Cha JH; Park JY; Lee BR; Jung SA; Lee ST; Yun CW; Seol DW; Kim TH
    Exp Cell Res; 2006 Nov; 312(19):3892-8. PubMed ID: 16996498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-level expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Wang D; Shi L
    Appl Biochem Biotechnol; 2009 Apr; 157(1):1-9. PubMed ID: 19306078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7.
    Bremer E; Samplonius DF; Peipp M; van Genne L; Kroesen BJ; Fey GH; Gramatzki M; de Leij LF; Helfrich W
    Cancer Res; 2005 Apr; 65(8):3380-8. PubMed ID: 15833872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.
    Tanaka H; Ito T; Kyo T; Kimura A
    Eur J Haematol; 2007 May; 78(5):389-98. PubMed ID: 17432976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
    Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS
    J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adeno-associated virus mediated tumor necrosis factor related apoptosis inducing ligand gene transfected into hepatocellular carcinoma cells by ultrasound microbubble intensifier: an experimental study].
    Xia JT; Xu B; Wang SC; Lai YY; Wu ZF; Li SH; Li W
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1846-50. PubMed ID: 19040022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and characterization of two versions of bifunctional EGFP-sTRAIL fusion proteins.
    Shen J; Wu Y; Shi L; Liu J; Liu S; Guan Z; Yin Z
    Appl Microbiol Biotechnol; 2007 Aug; 76(1):141-9. PubMed ID: 17562041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.
    Mohr A; Albarenque SM; Deedigan L; Yu R; Reidy M; Fulda S; Zwacka RM
    Stem Cells; 2010 Nov; 28(11):2109-20. PubMed ID: 20882532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation.
    Nomura S; Ishii K; Inami N; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
    Transpl Immunol; 2007 Nov; 18(2):115-21. PubMed ID: 18005854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Lin Z; Lei H; Cao P
    Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
    Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAIL in the mandarin fish Siniperca chuatsi: gene and its apoptotic effect in HeLa cells.
    Gao Y; Chang MX; Sun BJ; Nie P
    Fish Shellfish Immunol; 2008 Jan; 24(1):55-66. PubMed ID: 18083044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
    Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S
    Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
    Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P
    Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pVAX1 plasmid vector-mediated gene transfer of soluble TRAIL suppresses human hepatocellular carcinoma growth in nude mice.
    Zhang Y; Ma CH; Liu H; Zhang XM; Sun WS
    Acta Biochim Pol; 2007; 54(2):307-13. PubMed ID: 17546204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal protein S6 is a selective mediator of TRAIL-apoptotic signaling.
    Jeon YJ; Kim IK; Hong SH; Nan H; Kim HJ; Lee HJ; Masuda ES; Meyuhas O; Oh BH; Jung YK
    Oncogene; 2008 Jul; 27(31):4344-52. PubMed ID: 18362888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T
    Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and expression of sTRAIL-melittin combining enhanced anticancer activity with antibacterial activity in Escherichia coli.
    Liu H; Han Y; Fu H; Liu M; Wu J; Chen X; Zhang S; Chen Y
    Appl Microbiol Biotechnol; 2013 Apr; 97(7):2877-84. PubMed ID: 23149754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage.
    Jin CY; Park C; Moon SK; Kim GY; Kwon TK; Lee SJ; Kim WJ; Choi YH
    Anticancer Drugs; 2009 Sep; 20(8):713-22. PubMed ID: 19617819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.